AI brief of an SEC Form 8-K · Enovis (ENOV)

Enovis Q2 sales rise 7% to $565 million; 2025 revenue and EPS outlook raised

Mixed Impact 4 of 5 earnings Written later

Enovis reported second-quarter 2025 net sales of $565 million, up 7% on a reported basis, and raised its full-year 2025 revenue, adjusted EBITDA and adjusted EPS guidance. The company still posted a larger GAAP net loss of $37 million, or $0.64 per share, compared with a loss of $18.5 million, or $0.34 per share, a year earlier.

Key points

  • Q2 2025 net sales of $565 million, up 7% reported and 5% organic, versus the prior-year quarter
  • Q2 net loss of $37 million ($0.64 per share) versus a net loss of $18.5 million ($0.34 per share) in Q2 2024; adjusted EPS was $0.79 versus $0.62
  • Full-year 2025 revenue guidance raised to $2.245-2.275 billion from $2.220-2.250 billion; adjusted EPS guidance raised to $3.05-3.20 from $2.95-3.10
  • Q2 included a $10.0 million charge for the purchase of a royalty interest; adjusted EBITDA was $97 million, or 17.2% of sales

The filing

CompanyEnovis (ENOV)
Form8-K, current report
Filed with the SECAug 7, 2025, 6:11 AM ET
Accession number0001420800-25-000029

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.